Home » Topics » Regulatory » Patents

Patents
RSS

Hawaii Biotech describes new Botulinum neurotoxin type A light chain inhibitors

Oct. 31, 2016

AbbVie discloses novel TNF-alpha modulators

Oct. 31, 2016

Plexxikon divulges FLT3 mutant inhibitors for leukemia

Oct. 28, 2016

Dana-Farber Cancer Institute patent describes CDK inhibitors

Oct. 28, 2016

Eisai reports FGFR-4 inhibitors for liver cancer

Oct. 28, 2016

Gedeon Richter patents MCH1 receptor antagonists

Oct. 28, 2016

Shanghai Huilun Life Science & Technology patents PARP-1 inhibitors

Oct. 28, 2016

Merck & Co. develops FXIa and/or plasma kallikrein inhibitors

Oct. 27, 2016

Eli Lilly describes GOAT inhibitors

Oct. 27, 2016

Hangzhou Innogate Pharma discloses IDO-1 and/or TDO inhibitors

Oct. 27, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.